Overview

Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Type 2 diabetes mellitus (T2DM) is characterized by wide fluctuations of glucose. The long-acting insulin has showed to improve glycemic variability however the behavior of insulin glargine versus insulin degludec is unknown.
Phase:
Phase 4
Details
Lead Sponsor:
University of Guadalajara
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc
Insulin, Long-Acting